Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05275972
PHASE3

Descemet Endothelial Thickness Comparison Trial II

Sponsor: Stanford University

View on ClinicalTrials.gov

Summary

Descemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs endothelial dystrophy to DMEK versus Descemet Stripping Only (DSO) with adjunctive Ripasudil.

Official title: Descemet Endothelial Thickness Comparison Trials (DETECT I & II)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2023-01-23

Completion Date

2028-11-30

Last Updated

2025-12-18

Healthy Volunteers

No

Interventions

DRUG

Ripasudil

Topical Ripasudil 0.4%

DRUG

Placebo

Topical Placebo

Locations (7)

Stanford University

Palo Alto, California, United States

University of California Davis

Sacramento, California, United States

University of Miami

Palm Beach Gardens, Florida, United States

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States

Oregon Health & Science University

Portland, Oregon, United States

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Wills Eye Hospital

Philadelphia, Pennsylvania, United States